C10RF32 antibodies, and uses thereof for treatment of cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9617336
SERIAL NO

14360694

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to C1ORF32-specific antibodies, antibody fragments, alternative scaffolds, conjugates and compositions comprising same, for treatment of cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • COMPUGEN LTD.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Briante, Raffaella Burlingame, US 10 20
Cojocaru, Gady S Ramat Hasharon, IL 4 31
Dassa, Liat Yehud, IL 39 131
Levi, Ofer Moshav Mesilat Zion, IL 12 122
Levine, Zurit Herzliyya, IL 78 1054
Pergam, Tania Rishon LeZion, IL 12 35
Rotman, Galit Herzliyya, IL 47 475
Singh, Shweta Fremont, US 36 279
Watson, Susan R El Cerrito, US 11 222

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 11, 2024
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 11, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00